topoisomerase I/II inhibitors (BTG)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nametopoisomerase I/II inhibitors (BTG)
Drug Alias Nametopoisomerase I/II inhibitors (BTG/Napier)NU:UB-199topoisomerase I/II inhibitors (Napier University/Bradford University)NU:UB-150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitorsBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyraseDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNapier University of Edinburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNapier University of EdinburghBtg Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A